CRZO News Alert Carrizo Oil & Gas (CRZO) 33.29 12/13/2014 06

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Carrizo Oil & Gas (CRZO) 33.29 $CRZO

Carrizo Oil & Gas (CRZO) Falls: Stock Goes Down 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 7:32AM CST
Shares of Carrizo Oil & Gas (CRZO) fell by nearly 6% on the day. This continues the most recent downtrend for CRZO, as the stock is down nearly 38% since Nov 21. So make sure to keep an eye on this stock going forward to see if yesterday’s price decline is confirmed by more weakness.
SDR: 4.51 (-0.07), LNG: 64.88 (+0.93), CRZO: 33.29 (-0.34), ARP: 9.98 (-0.07)

Cramer's Mad Money - 3 Cheers For Merck (12/8/14)
SA Editor Miriam Metzinger - Seeking Alpha - Tue Dec 09, 5:29AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday December 8. Three Cheers for Merck (NYSE: MRK ). Other stock mentioned: Cubist Pharmaceuticals (NASDAQ: CBST ) "Three cheers for Merck," said...
SBUX: 83.25 (+0.13), CY: 13.63 (+0.12), CBST: 96.31 (+0.04), NKE: 96.17 (-0.76), MRK: 57.72 (-1.62), MCD: 90.62 (-0.35), DIS: 91.49 (-0.26), ENB: 46.95 (-1.06), CRZO: 33.29 (-0.34), KPTI: 34.85 (+1.35)

Jim Cramer's Top Stock Picks: DIS SBUX NKE ENB MRK CRZO
at The Street - Tue Dec 09, 5:00AM CST
The recent selloff means it's time to buy Disney, Starbucks, Nike and Enbridge, Cramer says.
SBUX: 83.25 (+0.13), CBST: 96.31 (+0.04), NKE: 96.17 (-0.76), MRK: 57.72 (-1.62), DIS: 91.49 (-0.26), ENB: 46.95 (-1.06), CRZO: 33.29 (-0.34)

Jim Cramer's 'Mad Money' Recap: Why You Should Buy Disney, Starbucks, Nike Now
at The Street - Mon Dec 08, 7:34PM CST
Not only do all three have impressive growth, but they benefit from falling oil prices, Cramer says.
NKE: 96.17 (-0.76), ED: 64.11 (-0.32), DIS: 91.49 (-0.26), JBLU: 14.81 (-0.48), SBUX: 83.25 (+0.13), CBST: 96.31 (+0.04), XLNX: 45.16 (-0.88), KBR: 15.26 (-0.47), MRK: 57.72 (-1.62), APA: 56.44 (-0.60), ENB: 46.95 (-1.06), CRZO: 33.29 (-0.34), LINE: 12.01 (-1.32), TASR: 23.19 (unch), KPTI: 34.85 (+1.35)

Oil and Gas Exploration and Production Stocks Technical Data - Memorial Resource Development, SM Energy, Carrizo Oil and Gas, Resolute Energy, and Atlas Resource Partners
PR Newswire - Mon Dec 08, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Memorial Resource Development Corporation (NASDAQ: MRD), SM Energy Company (NYSE: SM), Carrizo Oil and Gas Inc. (NASDAQ: CRZO), Resolute Energy Corporation (NYSE: REN), and Atlas Resource Partners L.P. (NYSE: ARP). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, December 05, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,958.79, up 0.33% and the NASDAQ Composite closed at 4,780.76, up 0.24%. The S&P 500 finished the session 0.17% higher at 2,075.37. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Energy Sector Index ended the day at 591.53, down 1.19%, with the index declining 14.70% in the previous three months. Register for your complimentary reports on these five stocks at:
REN: 1.10 (-0.11), MRD: 18.08 (+0.39), CRZO: 33.29 (-0.34), SM: 30.84 (+0.55), ARP: 9.98 (-0.07)

Eagle Ford produces billionth barrel of oil
Seeking Alpha - at Seeking Alpha - Fri Dec 05, 4:38PM CST

TLM: 4.29 (+0.60), FST: 0.36 (-0.04), XOM: 86.60 (-2.60), GDP: 3.93 (-0.33), MUR: 44.92 (-0.74), COG: 30.09 (+0.56), BHP: 46.18 (-0.92), CHK: 17.24 (+0.53), EOG: 86.37 (-0.49), APA: 56.44 (-0.60), BP: 36.24 (-1.09), CRZO: 33.29 (-0.34), MTDR: 15.24 (+0.04), APC: 73.34 (-1.91), HES: 66.53 (-1.33), ZAZA: 1.46 (-0.13), COP: 62.45 (-1.16), SN: 6.95 (-0.13), SM: 30.84 (+0.55), PVA: 4.84 (-0.04), ROSE: 18.47 (-1.68), CWEI: 51.45 (-1.51), MHR: 3.32 (-0.14), RDS.B: 63.77 (-1.77), NFX: 24.13 (+0.11), PXD: 131.25 (+0.65), RDS.A: 62.32 (-1.49), SFY: 3.08 (-0.09), MRO: 25.45 (-0.80), CRK: 5.26 (-0.49), STO: 16.23 (-0.48)

Carrizo Oil & Gas Announces Participation in Upcoming Conferences
GlobeNewswire - Thu Dec 04, 5:30AM CST
Carrizo Oil & Gas, Inc. (Nasdaq:CRZO) today announced that management is scheduled to present at the following upcoming conferences. A webcast of the presentations, if available, as well as the slide books used can be accessed on the Carrizo website at http://www.carrizo.com/ under the "Investor Relations" section.
WFC: 53.70 (-0.73), CRZO: 33.29 (-0.34)

Oil & Gas Stocks: 'Black Friday' And Updated Correction Scorecards
Richard Zeits - at Seeking Alpha - Mon Dec 01, 4:56AM CST
"Black Friday" The sharp decline last Friday (November 28) brought many Oil & Gas stocks further into the negative territory for the year and to their lowest trading levels in a long time. Many large-capitalization equities in the...
SD: 1.79 (unch), WLL: 27.61 (-1.32), CLR: 31.89 (-1.35), XOM: 86.60 (-2.60), SN: 6.95 (-0.13), SDRL: 11.06 (-0.15), BCEI: 18.57 (-0.79), PVA: 4.84 (-0.04), TPLM: 4.06 (-0.18), LPI: 7.76 (unch), SSE: 4.58 (-0.12), CWEI: 51.45 (-1.51), RDS.A: 62.32 (-1.49), CRZO: 33.29 (-0.34), LINE: 12.01 (-1.32), CVX: 102.38 (-2.53), EPE: 7.47 (-0.63), SPN: 17.44 (-0.53), OAS: 12.33 (+1.28)

Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 28, 1:11PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
GLNG: 34.68 (-1.63), LNCO: 11.03 (-0.36), MCEP: 6.50 (-0.07), REXX: 5.18 (+0.03), LINE: 12.01 (-1.32), CRZO: 33.29 (-0.34), PDCE: 33.13 (-0.89), ROSE: 18.47 (-1.68), AREX: 5.16 (-0.41)

Carrizo Oil & Gas Earnings Hindsight: Up 7.7% in Last 18 Days (CRZO)
Comtex SmarTrend(R) - Mon Nov 24, 9:20AM CST
18 days ago, on November 6th, 2014, Carrizo Oil & Gas (NASDAQ:CRZO) reported its earnings. Analysts, on average, expected earnings of $0.64 per share on sales of $186.7 million. The company actually reported EPS of $0.69 on sales of $188.5 million, beating EPS estimates by $0.05 and beating revenue estimates by $1.8 million. Since the company's report, shares of Carrizo Oil & Gas have risen from $49.84 to $53.66, representing a gain of 7.7% in the past 18 days.
CRZO: 33.29 (-0.34)

Carrizo Oil & Gas Earnings Hindsight: Up 3.5% in Last 11 Days (CRZO)
Comtex SmarTrend(R) - Mon Nov 17, 3:14PM CST
When Carrizo Oil & Gas (NASDAQ:CRZO) reported earnings a week ago on November 6th, 2014, analysts, on average, expected the company to report earnings of $0.64 on sales of $186.7 million. Carrizo Oil & Gas actually reported earnings of $0.69 per share on sales of $188.5 million, beating EPS estimates by $0.05 and beating revenue estimates by $1.8 million. Shares of Carrizo Oil & Gas have climbed from $49.84 to $51.59, representing a gain of 3.5% since the company reported earnings 11 days ago.
CRZO: 33.29 (-0.34)

Barrel Of Oil Equivalents - Accounting Gimmick?
Nick Rokke - at Seeking Alpha - Thu Nov 13, 12:33PM CST

WLL: 27.61 (-1.32), CLR: 31.89 (-1.35), EOG: 86.37 (-0.49), SGY: 13.64 (+0.08), MRO: 25.45 (-0.80), CRZO: 33.29 (-0.34), OAS: 12.33 (+1.28)

Peak What? Is It Safe?
The Nattering Naybob - at Seeking Alpha - Wed Nov 12, 7:02AM CST

HK: 2.01 (-0.09), EXXI: 2.84 (unch), SLB: 80.00 (-3.01), LNCO: 11.03 (-0.36), SCTY: 50.02 (-0.89), UGAZ: 9.34 (+0.69), PSX: 65.68 (-1.14), EXC: 35.92 (-0.35), REX: 58.45 (-0.26), EOX: 0.97 (-0.31), TPLM: 4.06 (-0.18), HNR: 1.79 (-0.05), CLB: 112.52 (-0.26), CPE: 4.54 (+0.27), PDCE: 33.13 (-0.89), DWTI: 99.11 (+8.53), OAS: 12.33 (+1.28), D: 72.72 (-0.65), KMI: 39.17 (-0.71), F: 14.99 (-0.29), BPZ: 0.24 (unch), UNG: 19.22 (+0.58), FCX: 21.78 (-1.20), MXWL: 8.63 (-0.47), UNT: 30.82 (-0.73), ECA: 12.19 (-0.39), QEP: 19.37 (-0.63), TRP: 45.11 (-0.36), CHK: 17.24 (+0.53), DGAZ: 4.22 (-0.40), REN: 1.10 (-0.11), FCG: 10.38 (-0.09), GPRE: 21.54 (-0.42), OIL: 13.71 (-0.48), APA: 56.44 (-0.60), EPL: 37.73 (+0.26), CRZO: 33.29 (-0.34), LINE: 12.01 (-1.32), SYRG: 10.07 (+0.58), PEIX: 10.17 (-0.47), UDNT: 12.83 (+0.12), BHI: 54.99 (-0.78), SN: 6.95 (-0.13), PVA: 4.84 (-0.04), EQU: 5.45 (unch), MHR: 3.32 (-0.14), SLCA: 24.20 (-1.89)

How Much Does It Cost To Produce One Barrel Of Oil? (Tight Oil, Part I)
Christoph Aublinger - at Seeking Alpha - Tue Nov 11, 7:39AM CST

CLR: 31.89 (-1.35), EOG: 86.37 (-0.49), CRZO: 33.29 (-0.34), BCEI: 18.57 (-0.79)

Insider Trading Alert - CRZO, SEIC And MOH Traded By Insiders
at The Street - Mon Nov 10, 10:00AM CST
Stocks with insider trader activity include CRZO, SEIC and MOH
SEIC: 39.56 (-0.69), CRZO: 33.29 (-0.34), MOH: 51.26 (+0.39)

Carrizo Oil & Gas (CRZO) Upgraded From Hold to Buy
at The Street - Mon Nov 10, 8:29AM CST
Carrizo Oil & Gas (CRZO) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
CRZO: 33.29 (-0.34)

Carrizo Oil & Gas' (CRZO) CEO Sylvester Johnson on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 2:30PM CST

CRZO: 33.29 (-0.34)

Carrizo slips despite Q3 beat, says Utica negotiations at advanced stage
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 9:59AM CST

CRZO: 33.29 (-0.34)

Carrizo Oil & Gas (CRZO) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 9:55AM CST

CRZO: 33.29 (-0.34)

Carrizo tops Street 3Q forecasts
Automated Insights - Thu Nov 06, 5:54AM CST
HOUSTON (AP) _ Carrizo Oil & Gas Inc. (CRZO) on Thursday reported third-quarter net income of $83.8 million.
CRZO: 33.29 (-0.34)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Elis Announces Share Buyback Operations Details and Impact

Updated Category News Views 257

Elis Announces Share Buyback Operations Recent Trading Disclosure by Elis In alignment with European regulations governing share buybacks, Elis has disclosed transactions for the purchase of its own shares. These operations occurred from September 15 to September 19, 2025, as part of an authorized buyback program approved by the General Shareholders' Meeting earlier in...

Continue Reading
One Stop Systems Set To Showcase Innovations at ROTH Event

Updated Category News Views 122

One Stop Systems Announces Participation in Major Conference One Stop Systems, Inc. (OSS), renowned for its cutting-edge solutions in rugged Enterprise Class computing, is gearing up to engage with investors at a prominent industry event. This year, OSS will be present at the 37th Annual ROTH Conference, scheduled for mid-March. The event will serve as a platform for the...

Continue Reading
Solid Biosciences to Engage at BioPharma Symposium Soon

Updated Category News Views 80

Solid Biosciences to Participate at BioPharma Symposium Solid Biosciences Inc. (NASDAQ: SLDB), a pioneering life sciences company, is excited to announce a significant upcoming event where they will showcase their advancements in the field of precision genetic medicine. The company's Chief Medical Officer, Dr. Gabriel Brooks, is scheduled to participate in a Genetic...

Continue Reading
JD Vance Confronted by Protesters While Out with Daughter

Updated Category News Views 378

Intense Encounter for Vice President JD Vance Recently, Vice President JD Vance found himself in a challenging situation when he was confronted by a group of pro-Ukraine protesters while spending time with his daughter. This encounter, which took place in Ohio, captured not only the essence of political tensions but also brought forth the complexities of personal moments...

Continue Reading
Exciting Addition to MyCardiologist as Dr. Koshy Joins Team

Updated Category News Views 325

New Addition to MyCardiologist Enhances Cardiovascular Care MyCardiologist, a leading name in advanced cardiovascular care, proudly announces the joining of Dr. Linda Koshy to their reputable medical team. Dr. Koshy is a skilled general and interventional cardiologist known for her exceptional ability to manage intricate coronary artery disease as well as endovascular...

Continue Reading